Connect with Michael Annichine

Michael Annichine

CEO Magee-Womens Research Institute & Foundation

Michael Annichine is the CEO of Magee-Womens Research Institute & Foundation (MWRIF), where he leads the development to sustain programs and research at UPMC Magee-Womens Hospital and Magee-Womens Research Institute, the largest research institute in the U.S. focused solely on women’s health and reproductive biology.

The research institute, based in Pittsburgh and building collaborations around the world, is home to hundreds of world-class researchers who have devoted their careers to advancing the health of women. MWRI’s medical research spans a woman’s lifetime from nine months to 90+ years and focuses on improving women’s lives by learning more about the various conditions and diseases from which they suffer.

Under Michael’s leadership since 2016, MWRIF has expanded its partnerships with industry, academia, and foundations and significantly grown its revenue base while capitalizing on the translational impact of its scientific investment. Michael is a seasoned professional with more than 20 years’ experience starting, developing, and leading local and national businesses across a variety of growth industries.

Prior to his current position, Michael held the Chief Executive roles at C-leveled, FlyerCity Media, and CFS Home Loans, Inc. where his companies were twice named to the Inc. 1000 Fastest Growing Companies in America list. A Carnegie Mellon University alumnus and former Director of Investment Programs at the Pittsburgh Life Sciences Greenhouse, Michael has measurably impacted the Pittsburgh start-up community and built strong connections with business, private equity, and venture capital partners.

Our website uses cookies, including third parties’ profiling cookies, to improve the functionality of the site and your user experience. You can learn more about how we use cookies and how to change your cookies settings in our Privacy Policy. By closing this message, clicking below or continuing to use this site, you consent to our use of cookies.